Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients

doi:10.12998/wjcc.v8.i17.3763

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4827)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

330

WORD

166

HTML

2363

Figures (1-4)

225

Tables (1-2)

183

Sum=3267

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

693

Download

867

Sum=1560

Sep 6, 2020 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 6, 2020; 8(17): 3763-3773
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3763

Full Size Figure Download Figure

Figure 2 Chest radiography in a patient who subsequently died after tocilizumab treatment (bedside chest radiograph show increased inflammation and significantly increased exudation).

Citation: Zeng J, Xie MH, Yang J, Chao SW, Xu EL. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients. World J Clin Cases 2020; 8(17): 3763-3773
URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3763.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3763